Detailed overview of paediatric ovarian germ cell tumours, types , diagnosis, detailed medical and surgical management. Also describe how the management is different from adult ovarian germ cell tumours. Describe using tables and flow chart s wherever applicable. Give the document in pdf format
"ovarian germ cell tumors" AND pediatric AND management
"ovarian germ cell tumors" AND chemotherapy AND fertility
Paediatric Ovarian GCT
PDF Document · PDF
| Section | Content |
|---|---|
| 1. Epidemiology | Incidence table comparing paediatric vs adult, age peaks, prognosis overview |
| 2. WHO Classification & Types | Full WHO classification table; detailed entries for dysgerminoma, YST (Schiller-Duval bodies), immature teratoma with Norris grading table, embryonal carcinoma, choriocarcinoma, mixed GCTs, dermoid cysts |
| 3. Clinical Presentation & Diagnosis | Symptoms frequency table; tumour markers table (AFP with age-adjusted norms caveat for infants - critical boxed note); imaging modality table |
| 4. FIGO 2014 Staging | Full stage IA through IV staging table |
| 5. Surgical Management | Principles of USO + conservation; stage-by-stage surgical approach table; DSD/gonadal dysgenesis; flowchart for surgical decision-making |
| 6. Chemotherapy | BEP regimen table (dose/route/mechanism); cycles-by-stage table; toxicity table with paediatric-specific notes (ototoxicity, secondary leukaemia, pulmonary); alternative regimens (carboplatin/etoposide, TIP, EMA-CO, HDCT/ASCT); radiation role; chemotherapy decision flowchart |
| 7. Fertility & Hormones | Fertility outcomes data (2025 systematic review); HRT for bilateral oophorectomy cases |
| 8. Surveillance | Time-based surveillance protocol table; growing teratoma syndrome |
| 9. Prognosis | Survival by tumour type and stage |
| 10. Paediatric vs Adult Comparison | 18-row detailed comparison table covering biology, markers, grading significance, cisplatin ototoxicity, bleomycin omission, etoposide secondary malignancy, DSD, surgical approach, follow-up |
| 11. MDT | 11-member team roles table |
| 12. Emerging Concepts | 2025 controversies (carboplatin vs cisplatin, bleomycin omission, surveillance vs chemo in stage IA YST, immunotherapy); recurrence management |
| 13. References | 10 key references including PMIDs for recent literature |
I can't open above PDF
Paediatric Ovarian GCT
PDF Document · PDF
| Type | Key Marker | Malignant? |
|---|---|---|
| Dysgerminoma | LDH, PLAP | Yes |
| Yolk Sac Tumour | AFP | Yes |
| Immature Teratoma | AFP (mild) | Yes (grade-dependent) |
| Embryonal Carcinoma | AFP + hCG | Yes |
| Choriocarcinoma | hCG | Yes |
| Mature Cystic Teratoma | None | No (benign) |
| Mixed GCT | Multiple | Yes |
Yes, generate in word format
Paediatric Ovarian GCT
Word Document · DOCX
| Section | Includes |
|---|---|
| 1. Epidemiology | Comparison table paediatric vs adult |
| 2. WHO Classification & Types | Classification table + detailed entries for all 7 tumour types; Norris grading table for immature teratoma |
| 3. Clinical Presentation | Symptoms table; tumour markers table with age-adjusted AFP warning box; imaging table |
| 4. FIGO 2014 Staging | Full staging table (IA through IV) |
| 5. Surgical Management | Principles; stage-by-stage surgical table; special considerations; flowchart |
| 6. Chemotherapy | BEP regimen table; cycles-by-stage table; toxicity table; alternatives table; flowchart |
| 7. Fertility & Hormones | Outcomes data; HRT guidance |
| 8. Surveillance | Protocol table; growing teratoma syndrome |
| 9. Prognosis | Survival table by type and stage |
| 10. Paediatric vs Adult | 16-row detailed comparison table |
| 11. MDT | Team roles table |
| 12. Emerging Concepts | 2024–2025 controversies; recurrence management |
| 13. References | 10 key references with PMIDs |